DB16158InvestigationalProtein Based Therapies
Epafipase is under investigation in clinical trial NCT00037687 (Safety and Efficacy of Recombinant Human Platelet-activating Factor Acetylhydrolase for the Treatment of Severe Sepsis).
- Also known as
- RPAF-AH
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Epafipase, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account